Journal of the Formosan Medical Association = Taiwan yi zhi · 2026
Real-world comparison of minilaparotomy versus laparoscopy-assisted minilaparotomy myomectomy for complex uterine myomas.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lee Chia-Yi, Hsu Ya-Ting, Hsu Heng-Cheng, Hung Wan-Ting, Chen Chi-Hau
Аннотация
OBJECTIVE: To directly compare perioperative and one-year postoperative outcomes of minilaparotomy myomectomy (MM) and laparoscopy-assisted minilaparotomy myomectomy (LAM) in managing complex uterine myomas.
METHODS: This retrospective study included 140 patients who underwent MM (n = 55) or LAM (n = 85) between 2015 and 2023 at a tertiary center. Demographic data, surgical outcomes, and one-year postoperative evaluations were analyzed. Multivariable linear regression identified factors associated with operative time and blood loss.
RESULTS: Preoperative characteristics and myoma burden were comparable (mean 3.49 myomas; maximum 8.3 cm). MM had shorter operative time and hospital stay (both p < .001). Three MM cases required wound extension, while no conversions occurred in the LAM group (p = .030). Over 92% of patients achieved symptom resolution at one year, with similar rates of residual myoma and reoperation. LAM use, adhesions, myoma number, and myoma size predicted longer operative time, whereas blood loss correlated with wound size, myoma number and size, and intraligamentous type.
CONCLUSION: Both MM and LAM are effective surgical options for complex myomas, with favorable perioperative and one-year outcomes. These findings support their broader clinical use and offer practical insights for surgical decision-making.
METHODS: This retrospective study included 140 patients who underwent MM (n = 55) or LAM (n = 85) between 2015 and 2023 at a tertiary center. Demographic data, surgical outcomes, and one-year postoperative evaluations were analyzed. Multivariable linear regression identified factors associated with operative time and blood loss.
RESULTS: Preoperative characteristics and myoma burden were comparable (mean 3.49 myomas; maximum 8.3 cm). MM had shorter operative time and hospital stay (both p < .001). Three MM cases required wound extension, while no conversions occurred in the LAM group (p = .030). Over 92% of patients achieved symptom resolution at one year, with similar rates of residual myoma and reoperation. LAM use, adhesions, myoma number, and myoma size predicted longer operative time, whereas blood loss correlated with wound size, myoma number and size, and intraligamentous type.
CONCLUSION: Both MM and LAM are effective surgical options for complex myomas, with favorable perioperative and one-year outcomes. These findings support their broader clinical use and offer practical insights for surgical decision-making.